Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 140898-97-1
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the clinical use of hexaminolevulinate during breastfeeding. After instillation into the bladder, only about 7% of a dose is absorbed into the maternal bloodstream, so the amount of drug excreted into milk is expected to be minimal. Until more data become available, hexaminolevulinate should be used with caution during breastfeeding, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Hexaminolevulinate
CAS Registry Number
140898-97-1
Drug Class
- Breast Feeding
- Diagnostic Agents
- Photosensitizing Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Hexyl aminolevulinate: 5-ALA hexylester, 5-ALA hexylesther, aminolevulinic acid hexyl ester, hexaminolevulinate, hexyl 5-aminolevulinate, P 1206.[Drugs R D. 2005]Review Hexyl aminolevulinate: 5-ALA hexylester, 5-ALA hexylesther, aminolevulinic acid hexyl ester, hexaminolevulinate, hexyl 5-aminolevulinate, P 1206.. Drugs R D. 2005; 6(4):235-8.
- The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.[Photodiagnosis Photodyn Ther. ...]The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.Middelburg TA, de Bruijn HS, van der Ploeg-van den Heuvel A, Neumann HA, Robinson DJ. Photodiagnosis Photodyn Ther. 2013 Dec; 10(4):703-9. Epub 2013 Oct 15.
- Review Hexyl aminolevulinate: in the detection of bladder cancer.[Drugs. 2006]Review Hexyl aminolevulinate: in the detection of bladder cancer.Frampton JE, Plosker GL. Drugs. 2006; 66(4):571-8; discussion 579-80.
- Review Aminolevulinic Acid.[Drugs and Lactation Database (...]Review Aminolevulinic Acid.. Drugs and Lactation Database (LactMed®). 2006
- Review The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer.[Nat Clin Pract Urol. 2007]Review The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer.Witjes JA, Douglass J. Nat Clin Pract Urol. 2007 Oct; 4(10):542-9.
- Hexaminolevulinate - Drugs and Lactation Database (LactMed®)Hexaminolevulinate - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...